Johns Hopkins ABX Guide
Maraviroc
INDICATIONS
FDA
FDA
- Used in combination with other ARVs in ART-experienced adult patients infected with CCR5 (R5)-tropic HIV-1.
- Used in combination with other ARVs in ART-naive adult patients infected with CCR5 (R5)-tropic HIV-1 (not a DHHS preferred first line agent)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 25, 2015
Citation
Forrestel, Maureen M, et al. "Maraviroc." Johns Hopkins ABX Guide, The Johns Hopkins University, 2015. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540332/5.3/Maraviroc.
Forrestel MM, Pham PA, Hsu AJ. Maraviroc. Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540332/5.3/Maraviroc. Accessed June 10, 2023.
Forrestel, M. M., Pham, P. A., & Hsu, A. J. (2015). Maraviroc. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540332/5.3/Maraviroc
Forrestel MM, Pham PA, Hsu AJ. Maraviroc [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. [cited 2023 June 10]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540332/5.3/Maraviroc.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Maraviroc
ID - 540332
A1 - Forrestel,Maureen,Pharm.D.
AU - Pham,Paul,Pharm.D.
AU - Hsu,Alice,Pharm.D.
Y1 - 2015/09/25/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540332/5.3/Maraviroc
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
